Marker Therapeutics Secures $16.2M Grant for MT-601
Houston, Texas, United States, November 19, 2026 Marker Therapeutics, Inc. has been awarded a $16.2 million Product Development Research...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 Clinical Trial Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Houston, Texas, United States, November 19, 2026 Marker Therapeutics, Inc. has been awarded a $16.2 million Product Development Research...
Milford, Massachusetts, United States, November 10, 2026 Waters Corporation has announced that two ready-to-use flow cytometry clinical tests from...
Florence, Italy, and Kraków, Poland, November 4, 2026 Menarini Group, together with its oncology subsidiary Stemline Therapeutics and Ryvu...
SOUTH SAN FRANCISCO, Calif. — September 16, 2026 Genentech announced that the Phase III CELESTIMO study of Lunsumio® (mosunetuzumab-axgb)...
HYDERABAD, India, Aug. 1, 2026 Dr. Reddy’s Laboratories Ltd. announced that the U.S. Food and Drug Administration (FDA) has...
BEIJING, Aug. 4, 2026 InnoCare Pharma announced that the China National Medical Products Administration (NMPA) Center for Drug Evaluation...
BRONX, New York, July 6, 2026 Montefiore Einstein investigators have published new research demonstrating that expanding the use of...
LONDON, United Kingdom, July 6, 2026 AMO Pharma Limited has announced a significant regulatory milestone for its investigational therapy...
NORTH CHICAGO, Illinois, July 6, 2026 AbbVie has announced that the European Commission (EC) has granted marketing authorization for...
WILMINGTON, Del., June 20, 2026 Incyte Biosciences Japan G.K. has announced that Japan’s Ministry of Health, Labour and Welfare...
